The company
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
TAK · NYSE
TAK stood above a rising 150-day average in 35 of the last 52 weekly readings, including each of the last 11 weeks. It is 13.1% above that average now. Pharmaceuticals: 32% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 11 in a row
- Industry in uptrend
- 32% -7 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $26.2M
- Officials’ trades on record
- 8
- Institutions holding
- 359 (+18)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 35 of 52 weeks.
Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
8 disclosed lines: House 8, Senate 0, executive 0; 4 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Virginia Foxx House: U.S. House ClerkNC05 | soldjoint | $15k–$50k | 29 Aug 2023filed 5 Sep 2023 |
| Daniel S. Goldman House: U.S. House ClerkNY10 | sold | $15k–$50k | 10 Jul 2023filed 13 Aug 2023 |
| Daniel S. Goldman House: U.S. House ClerkNY10 | bought | $1k–$15k | 27 Feb 2023filed 20 Mar 2023 |
| Virginia Foxx House: U.S. House ClerkNC05 | boughtjoint | $1k–$15k | 16 Feb 2023filed 3 Mar 2023 |
| Virginia Foxx House: U.S. House ClerkNC05 | boughtjoint | $1k–$15k | 1 Nov 2022filed 6 Dec 2022 |
| Greg Gianforte House: U.S. House ClerkMT00 | sold | $1k–$15k | 11 Sep 2019filed 20 Oct 2019 |
| Van Taylor House: U.S. House ClerkTX03 | sold | $15k–$50k | 25 Mar 2019filed 15 Apr 2019 |
| Greg Gianforte House: U.S. House ClerkMT00 | bought | $15k–$50k | 21 Dec 2018filed 23 Jan 2019 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Lauren Rusckowski DupreyChief Transformation Officer | sold | 34,535at $18.54 | 14 Sep 2026filed 15 Sep 2026 |
| Andrew Stewart PlumpPresident, R&D | sold | 116,191at $18.49 | 2 Sep 2026filed 3 Sep 2026 |
| Andrew Stewart PlumpPresident, R&D | sold | 19,651at $18.49 | 19 Aug 2026filed 21 Aug 2026 |
| Nicola Deidre Petal GreenwayChief Human Resources Officer | sold | 12,980at $18.11 | 18 Aug 2026filed 19 Aug 2026 |
| Elaine Mary ShannonPres., Global Supply & Quality | sold | 20,363at $17.55 | 11 Aug 2026filed 12 Aug 2026 |
| Nicola Deidre Petal GreenwayChief Human Resources Officer | sold | 975at $17.50 | 10 Aug 2026filed 12 Aug 2026 |
| Nicola Deidre Petal GreenwayChief Human Resources Officer | sold | 33,628at $17.51 | 10 Aug 2026filed 12 Aug 2026 |
| Natalie Anne Marie FurneyGlobal General Counsel | sold | 30,868at $17.10 | 10 Aug 2026filed 12 Aug 2026 |
| Giles Richard PlatfordPresident, IBU | sold | 31,083at $17.10 | 10 Aug 2026filed 12 Aug 2026 |
| Julie So-Young KimPresident and CEO | sold | 89,090at $17.10 | 10 Aug 2026filed 12 Aug 2026 |
| Nicola Deidre Petal GreenwayChief Human Resources Officer | sold | 6,774at $17.10 | 10 Aug 2026filed 12 Aug 2026 |
| Gabriele RicciChief Data & Tech. Officer | sold | 25,088at $17.10 | 10 Aug 2026filed 12 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Capital Research Global Investorsadded · filed 12 Aug 2026 | 19,297,680$309.3M | +193,461+1.0% |
| FMR LLCadded · filed 13 Aug 2026 | 9,599,302$153.9M | +2,481,816+34.9% |
| MORGAN STANLEYadded · filed 13 Aug 2026 | 6,994,924$112.1M | +525,324+8.1% |
| ADAGE CAPITAL PARTNERS GP, L.L.C.reduced · filed 14 Aug 2026 | 6,050,771$97.0M | -374,213−5.8% |
| GOLDMAN SACHS GROUP INCreduced · filed 14 Aug 2026 | 5,125,032$82.2M | -493,696−8.8% |
| BRANDES INVESTMENT PARTNERS, LPadded · filed 14 Aug 2026 | 4,539,347$72.8M | +108,705+2.5% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIPadded · filed 13 Aug 2026 | 3,732,924$59.8M | +616,613+19.8% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 3,688,166$59.1M | +511,745+16.1% |
| RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026 | 2,568,000$41.2M | -421,100−14.1% |
| Qube Research & Technologies Ltdnew · filed 14 Aug 2026 | 2,207,432$35.4M | +2,207,432 |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.